Braveheart Bio targets up to $318.8M in US IPO

Go back to Braveheart Bio targets up to $318.8M in US IPO
(NASDAQ: BRVE) Delayed: 23.61 -1.41 (5.64%)
Previous Close $25.02    52 Week High
Open $25.41    52 Week Low
Day High $25.41    P/E N/A 
Day Low $23.42    EPS
Volume 829,452